172P HER2 expression across solid tumors and real-world implications for use of fam-trastuzumab deruxtecan-nxki (T-Dxd).
Saved in:
| Title: | 172P HER2 expression across solid tumors and real-world implications for use of fam-trastuzumab deruxtecan-nxki (T-Dxd). |
|---|---|
| Authors: | Ismail, A.1 (AUTHOR), Modi, M.2 (AUTHOR), Kleckley, A.3 (AUTHOR), Midhun, M.1 (AUTHOR), Basu, A.1 (AUTHOR), Jahan, N.1 (AUTHOR), Gupta, G.1 (AUTHOR), El-Rayes, B.1 (AUTHOR), Mattox, T.4 (AUTHOR), Hawkins, C.5 (AUTHOR), Bae, S.6 (AUTHOR), Akce, M.7 (AUTHOR), Arend, R.8 (AUTHOR), Boumber, Y.9 (AUTHOR), Desai, A.10 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS284-S284. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.2177 |
